This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pharma Clinical Trial Services: World Market 2013-2023

Table 6.15 Infectious Disease Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.16 Metabolic Disease Clinical Trial Services Submarket Forecast, 2011-2023

Table 6.17 Metabolic Disease Clinical Trial Services Submarket: Drivers and Restraints, 2011-2023

Table 6.18 Selected Imaging Specialist CROs, 2012

Table 7.1 Pharma Clinical Trial Services Market: Strengths and Weaknesses, 2012

Table 7.2 Pharma Clinical Trial Services Market: Opportunities and Threats, 2013-2023

Table 7.3 Biosimilar Guidance Drafted Using Elements of EU Guidelines, 2008-2012

Table 7.4 Pharma Clinical Trial Services Market: STEP Analysis, 2013-2023

Table 7.5 Selected Online Communities to Aid Patient Recruitment and Trial Involvement, 2012

Table 7.6 Selected CROs Investing in Technology, 2011-2012

Table 7.7 Selected Sources of Biomarkers and Relevant Research Technology, 2012

Table 7.8 Growth in the Biomarker Services Market, 2011, 2016 & 2022

Table 8.1 World CRO Market by Company, 2011

Table 8.2 Covance: Revenue by Sector, 2007-2011

Table 8.3 Covance: Revenue by Sector, Q1-Q3 2011-2012

Table 8.4 PPD: Revenue by Sector, Q1-Q2 2010-2011

Table 8.5 Parexel International: Revenue by Sector, 2010-2012

Table 8.6 Parexel International: Revenue by Region, 2012

Table 8.7 ICON: Revenue by Sector, 2010-2011

Table 8.8 ICON: Revenue by Region, 2010-2011

Table 8.9 Kendle: Revenue by Sector, 2009-2010

Table 8.10 inVentiv Health: Revenue by Sector, Q2 2010 & Q2 2011

Table 8.11 CMIC: CRO Revenue, 2008-2012

Table 8.12 Chiltern International: Therapeutic Experience

Table 8.13 Chiltern International: Revenue, 2008-2010

Table 8.14 Selected Strategic Partnerships Signed, 2011-2012

Table 10.1 Pharma Clinical Trial Services Market by Sector, 2011, 2017 & 2023

List of Figures

Figure 2.1 A Brief History of Clinical Trials

Figure 3.1 Breakdown of Pharma Clinical Spending by Phase

Figure 3.2 Pharma Clinical Trial Services Market, 2008-2011

Figure 3.3 Pharma Clinical Trial Services Market by Sector, 2011

Figure 3.4 CRO Clinical Trial Services Revenue by Customer Type, 2011

Figure 3.5 Clinical Trial Services Market: Drivers and Restraints, 2013-2023

9 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs